Purchase Order 1243YK20P0048
Award Date 8/26/20
Potential Completion Date 9/30/20
Potential Value $32K
Federal Agency
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Athens, GA 30605, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price purchase order awarded by the Food and Drug Administration to Acea Biosciences, Inc., a small business, for a preventive maintenance agreement on the company's ACEA Biosciences/xCELLigence Real-Time Cell Analysis (RTCA) Dual Purpose (DP) unit. The ceiling value of the contract is $6,600.00 with a period of performance through September 12, 2024. Acea Biosciences, Inc. is a subsidiary of the parent company Agilent Technologies, Inc., a major provider of analytical...
- This federal contract was awarded by the Department of the Navy Bureau of Medicine and Surgery to Acea Biosciences, Inc., a subsidiary of Agilent Technologies, Inc. The $125,070.00 firm fixed price purchase order is for an XCELLIGENCE RTCA MP BUNDLE CAT# 00380601040, which is a real-time cell analysis system used in research laboratories. The contract does not have a set-aside designation. Acea Biosciences has received over 20 previous prime federal contracts from agencies like the Departments...
- <p>The National Cancer Institute awarded a purchase order to Acea Biosciences, Inc. for $15,480.00 on May 22, 2020, with completion scheduled for June 29, 2021. Work is performed in San Diego, California. The order is firm fixed price with no set-aside designation. Acea Biosciences is a subsidiary of Agilent Technologies and supplies life sciences instrumentation, software, consumables, and services to federal research organizations.</p>
- This contract was awarded by the Department of Health and Human Services National Institutes of Health National Cancer Institute to Acea Biosciences, Inc. for the acquisition of an xCELLigence RTCA-MP equipment package. The contract is a firm fixed-price purchase order with a potential value of $134,995.95. There was no set-aside designation for this award. Acea Biosciences is a life sciences company that provides specialized equipment, software, services, and expertise related to flow...
- This federal contract award was made by the National Institute on Drug Abuse, a civilian agency, to Acea Biosciences, Inc., a subsidiary of Agilent Technologies, Inc. The $4,987.50 firm fixed-price purchase order is for service agreement coverage of a NovoCyte Quanteon flow cytometer system and an xCELLigence RTCA CardioECR instrument. The award does not have a set-aside designation, indicating it was competed on a full and open basis. Acea Biosciences has received numerous prior federal...
- This federal contract award was made by the Food and Drug Administration (FDA) to Acea Biosciences, Inc., a subsidiary of Agilent Technologies, Inc. The contract is for the delivery of a flow cytometer with post-warranty service and maintenance options, for a total ceiling value of $53,640.00. The contract was awarded on a firm fixed-price basis, with no set-aside designation. Acea Biosciences has previously received numerous prime federal contract awards from various agencies, including the...
- This is a firm-fixed price purchase order contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Acea Biosciences, Inc., a life sciences company that provides laboratories worldwide with instruments, software, services, consumables, and expertise. The contract is for the supply of unspecified lab supplies, with a completion date of May 24, 2019 and a potential value of $253,362.00. The contract was not set aside for any special business...
- This federal contract award to Acea Biosciences, Inc. was issued by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services. The contract, valued at $96,213.60, is for the procurement of a small footprint high-dimensional flow cytometer. This equipment will be used to support research activities within the NCI. The contract has a firm fixed price pricing type and a completion date of November 16, 2016. Acea Biosciences is a life sciences company...
- This federal contract award was made by the National Cancer Institute, a civilian agency within the U.S. Department of Health and Human Services, to Acea Biosciences, Inc. for the acquisition of an xCELLigence RTCA-MP equipment package. The $99,000.00 firm fixed-price purchase order does not have a set-aside designation. Acea Biosciences, a for-profit life sciences company, has received over 20 prior federal contract awards from agencies including the USDA, HHS, VA, and Navy to provide...
- On September 19, 2018, the U.S. Department of Agriculture's Northeast Area awarded a $30,204 firm fixed-price purchase order to Acea Biosciences, Inc. for an impedance assay instrument system. The contract, issued under solicitation #AG-3JL0-S-18-0013, encompasses the delivery of a RTCA S16 Instrument (380601310) with control unit and E-Plate View 16 PET plates (6x6 configuration), with performance required by October 22, 2018. This award was not designated as a set-aside contract and represents...